ROFCX | VISVX | ROFCX / VISVX | |
Total Expense Ratio | 2.24 | 0.19 | 1,179% |
Annual Report Gross Expense Ratio | 2.34 | 0.19 | 1,232% |
Fund Existence | 19 years | 27 years | - |
Gain YTD | -11.308 | -4.142 | 273% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2000 | 3000 | 67% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 996M | 57.6B | 2% |
Annual Yield % from dividends | 0.00 | 2.14 | - |
Returns for 1 year | -12.85 | 1.29 | -996% |
Returns for 3 years | -16.72 | 9.10 | -184% |
Returns for 5 years | 83.74 | 137.90 | 61% |
Returns for 10 years | -12.56 | 79.80 | -16% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
NVD | 38.62 | 5.13 | +15.32% |
GraniteShares 2x Short NVDA Daily ETF | |||
TAFI | 25.12 | 0.05 | +0.20% |
AB Tax-Aware Short Duration ETF | |||
FTXH | 26.59 | -0.42 | -1.55% |
First Trust Nasdaq Pharmaceuticals ETF | |||
SHE | 109.93 | -5.09 | -4.42% |
SPDR® MSCI USA Gender Diversity ETF | |||
IGM | 85.77 | -6.44 | -6.98% |
iShares Expanded Tech Sector ETF |